Immunoglobulins, Intravenous: all 232 studies that test it
Page 1 of 3. Open to participants first (31), then studies with results posted, then the rest; newest registration first within each.
- Neonatal Outcomes on Direct Fetal Intravenous Immunoglobulin During Intrauterine Transfusion for Rhesus IsoimmunizationRecruitingNCT07885592Phase 2
- Stopping Strep Throat With Antibodies in Healthy Adults.Not yet recruitingNCT07864350Phase 1
- Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell TransplantationNot yet recruitingNCT07698080Phase 2
- Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary FibrosisNot yet recruitingNCT07674745Phase 2
- A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin LymphomaRecruitingNCT07582432Phase 3
- Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowRecruitingNCT07561125Phase 2
- A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff Person SyndromeNot yet recruitingNCT07552987Phase 3
- A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating PolyradiculoneuropathyRecruitingNCT07540221Phase 3
- Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary FibrosisRecruitingNCT07299695Phase 3
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)RecruitingNCT07202091Phase 2/3
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)RecruitingNCT07202078Phase 2/3
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)RecruitingNCT07202065Phase 2/3
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)RecruitingNCT07202052Phase 2/3
- A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)RecruitingNCT07059000Phase 3
- Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)RecruitingNCT07048262Phase 2
- A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple MyelomaRecruitingNCT06980480Phase 3
- V-IMMUNE: A Novel Immunoglobulin Therapy for ImmunodeficiencyRecruitingNCT06954441Phase 3
- IVIG Trial for the Treatment of Bronchopulmonary DysplasiaRecruitingNCT06925360Phase 2
- A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)RecruitingNCT06747351Phase 3
- The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing MyopathyRecruitingNCT06599697Phase 2
- Prednisone Plus IVIg vs. Prednisone for ITP During PregnancyRecruitingNCT06577909Phase 2
- A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)RecruitingNCT06533098Phase 3
- Role of Immunoglobulin in Male InfertilityRecruitingNCT06423989Not applicable
- IVIG in Painful Sensory NeuropathyNot yet recruitingNCT06183008Phase 4
- IVIG Boya: Safety, Efficacy, and PharmacokineticsNot yet recruitingNCT06150833Phase 3
- Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIGNot yet recruitingNCT06089122Phase 3
- Efficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Prospective StudyRecruitingNCT06009042Phase 4
- Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)RecruitingNCT05604859Phase 4
- Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in ChildrenRecruitingNCT05520892Phase 4
- Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2Enrolling by invitationNCT05350774Phase 2
- Autologous Stem Cell Transplantation in Patients With Systemic SclerosisRecruitingNCT03630211Phase 2
- A Study of TAK-881 and HyQvia in Healthy AdultsCompletedNCT06895967Phase 1Results posted
- Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in AdultsCompletedNCT05422365Phase 3Results posted
- A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult ParticipantsCompletedNCT04578535Phase 1Results posted
- Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory PneumonitisTerminatedNCT04438382Phase 2Results posted
- Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19CompletedNCT04411667Phase 4Results posted
- Octagam 10% Therapy in COVID-19 Patients With Severe Disease ProgressionCompletedNCT04400058Phase 3Results posted
- A Study of Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID)CompletedNCT04346108Phase 3Results posted
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)TerminatedNCT04044690Phase 3Results posted
- IVIG-eye Drops Treatment for Dry Eye DiseaseCompletedNCT03992482Phase 1/2Results posted
- Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID PatientsCompletedNCT03961009Phase 3Results posted
- IVIG (Gamunex-C) Treatment Study for POTS SubjectsCompletedNCT03919773Phase 1/2Results posted
- Cardiac Safe Transplants for Systemic SclerosisTerminatedNCT03593902Phase 2/3Results posted
- IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3CompletedNCT03401073Phase 2Results posted
- Anti-Hepatitis A Virus, Pharmacokinetics, and Safety of Immune Globulin (Human)CompletedNCT03351933Phase 4Results posted
- Maximizing Outcome of Multiple Sclerosis TransplantationTerminatedNCT03342638Phase 3Results posted
- Effect of IVIG on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer DiseaseCompletedNCT03319810Phase 2Results posted
- Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD SubjectsCompletedNCT03277313Phase 3Results posted
- Study of PlasmaCap IG in Adults and Children With PIDDCompletedNCT03238079Phase 3Results posted
- Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD SubjectsCompletedNCT03116347Phase 4Results posted
- KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)CompletedNCT03065244Phase 3Results posted
- Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDPCompletedNCT02955355Phase 3Results posted
- The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of DiabetesTerminatedNCT02915263Phase 2Results posted
- Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral ImmunodeficiencyCompletedNCT02783482Phase 3Results posted
- Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy)CompletedNCT02728752Phase 3Results posted
- IVIG in Patients With VGKC Ab Associated Autoimmune EpilepsyTerminatedNCT02697292Phase 3Results posted
- Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) NeuropathyCompletedNCT02638207Phase 3Results posted
- A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedNCT02549170Phase 3Results posted
- Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia GravisCompletedNCT02473965Phase 2Results posted
- A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia GravisCompletedNCT02473952Phase 2Results posted
- Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT02465359Not applicableResults posted
- A Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis ExacerbationsCompletedNCT02413580Phase 3Results posted
- Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With InfluenzaCompletedNCT02287467Phase 3Results posted
- Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% Dual Inactivation and Filtration (DIF) in Participants With Post-polio SyndromeTerminatedNCT02176863Phase 2/3Results posted
- Post-bypass Prophylactic IVIG in Infants and NeonatesCompletedNCT02043379Not applicableResults posted
- Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency DiseasesCompletedNCT01963143Phase 3Results posted
- Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary AtresiaCompletedNCT01854827Phase 1/2Results posted
- IVIg Efficacy Study to Treat Cutaneous Lupus ErythematosusCompletedNCT01841619Early Phase 1Results posted
- Long-Term Study of IGIV, 10% in Alzheimer´s DiseaseTerminatedNCT01736579Phase 3Results posted
- A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney TransplantationCompletedNCT01594424Phase 1/2Results posted
- Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)CompletedNCT01581593Phase 3Results posted
- A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated MyelopathyTerminatedNCT01561755Phase 4Results posted
- Multi-Drug Desensitization Protocol for Heart Transplant CandidatesTerminatedNCT01556347Phase 2Results posted
- IVIG Treatment for Refractory Immune-Related Adult EpilepsyTerminatedNCT01545518Phase 2Results posted
- Phase 3 IGIV, 10% in Alzheimer´s DiseaseTerminatedNCT01524887Phase 3Results posted
- Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic GanglionopathyCompletedNCT01522235Phase 2/3Results posted
- Pharmacokinetics, Safety, and Tolerability of Subcutaneous GAMUNEX-C in Pediatric Subjects With Primary ImmunodeficiencyCompletedNCT01465958Phase 4Results posted
- Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)CompletedNCT01458171Phase 3Results posted
- Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune ThrombocytopeniaCompletedNCT01349790Phase 3Results posted
- High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam)CompletedNCT01313507Phase 3Results posted
- Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive ImpairmentCompletedNCT01300728Phase 2Results posted
- A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary ImmunodeficiencyCompletedNCT01289847Phase 4Results posted
- Phase 2/3 Study of IGSC, 20% in PIDDCompletedNCT01218438Phase 2/3Results posted
- A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency DiseasesCompletedNCT01012323Phase 3Results posted
- Desensitization of Highly Sensitized Deceased Donor Renal Transplantation CandidatesTerminatedNCT00986947Phase 2Results posted
- Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)CompletedNCT00845650Phase 1/2Results posted
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s DiseaseCompletedNCT00818662Phase 3Results posted
- Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's DiseaseCompletedNCT00812565Phase 2Results posted
- Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency DiseasesTerminatedNCT00811174Phase 3Results posted
- Treatment of Multiple System Atrophy Using Intravenous ImmunoglobulinsCompletedNCT00750867Phase 2Results posted
- Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic PurpuraCompletedNCT00699140Phase 3Results posted
- Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor NeuropathyCompletedNCT00666263Phase 3Results posted
- Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant PatientsTerminatedNCT00586716Not applicableResults posted
- Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart DysfunctionCompletedNCT00547365Phase 1/2Results posted
- Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) SubjectsCompletedNCT00546871Phase 2/3Results posted
- IGIV Study for Chronic ITP Patients Ages 3-70CompletedNCT00511147Phase 3Results posted
- A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00504075Phase 3Results posted
- Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in AdultsCompletedNCT00426270Phase 3Results posted
- A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary ImmunodeficiencyCompletedNCT00389324Phase 2Results posted
- Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's DiseaseTerminatedNCT00299988Phase 2Results posted